Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive acanthamoeba keratitis: Report of 3 cases

Ophthalmology

Volumn 118, Issue 2, 2011, Pages 324-331

  Khan, Yasin A ^a   Kashiwabuchi, Renata T ^a   Martins, Suy Anne ^a   Castro Combs, Juan M ^a   Kalyani, Sachin ^a   Stanley, Philip ^a   Flikier, David ^b   Behrens, Ashley ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Instituto de Ciruga Ocular   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADJUVANT THERAPY; ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFOCAL MICROSCOPY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; SLIT LAMP; ULTRAVIOLET A RADIATION; VISUAL ACUITY;

ACANTHAMOEBA KERATITIS; ADULT; ANTIPROTOZOAL AGENTS; BENZAMIDINES; BIGUANIDES; CHEMOTHERAPY, ADJUVANT; CHLORHEXIDINE; CONTACT LENSES, HYDROPHILIC; CORNEAL ULCER; DRUG THERAPY, COMBINATION; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; ULTRAVIOLET RAYS; VISUAL ACUITY;

EID: 79551529107     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.06.041     Document Type: Article

References (44)

1. P. Wright, D. Warhurst, and B.R. Jones Acanthamoeba keratitis successfully treated medically Br J Ophthalmol 69 1985 778 782
2. I.G. Duguid, J.K. Dart, and N. Morlet Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine Ophthalmology 104 1997 1587 1592
3. S.L. Hargrave, J.P. McCulley, Z. Husseini Brolene Study Group Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis Ophthalmology 106 1999 952 957
4. J.J. Prez-Santonja, S. Kilvington, and R. Hughes Persistently culture positive Acanthamoeba keratitis: in vivo resistance and in vitro sensitivity Ophthalmology 110 2003 1593 1600
5. G.A. Stern, and D.W. Killingsworth Complications of topical antimicrobial agents Int Ophthalmol Clin 29 1989 137 142
6. W. Shi, M. Liu, and H. Gao Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment Graefes Arch Clin Exp Ophthalmol 247 2009 1383 1388
7. A.S. Bacon, D.G. Frazer, and J.K. Dart A review of 72 consecutive cases of Acanthamoeba keratitis, 19841992 Eye (Lond) 7 1993 719 725
8. J.H. Mah-Sadorra, S.G. Yavuz, and D.M. Najjar Trends in contact lens-related corneal ulcers Cornea 24 2005 51 58
9. S.J. Lee, H.J. Jeong, and J.E. Lee Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear Korean J Parasitol 44 2006 313 320
10. T.K. Butler, J.J. Males, and L.P. Robinson Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 19972002 Clin Exp Ophthalmol 33 2005 41 46
11. D.N. Parmar, S.T. Awwad, and W.M. Petroll Tandem scanning confocal corneal microscopy in the diagnosis of suspected Acanthamoeba keratitis Ophthalmology 113 2006 538 547
12. P.R. Badenoch The pathogenesis of Acanthamoeba keratitis Aust N Z J Ophthalmol 19 1991 9 20
13. S. Kilvington, D.F. Larkin, D.G. White, and J.R. Beeching Laboratory investigation of Acanthamoeba keratitis J Clin Microbiol 28 1990 2722 2725
14. G. Wollensak, E. Spoerl, and T. Seiler Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus Am J Ophthalmol 135 2003 620 627
15. M. Kohlhaas, E. Spoerl, and A. Speck A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking [in German] Klin Monbl Augenheilkd 222 2005 430 436
16. E. Schnitzler, E. Sprl, and T. Seiler Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes: preliminary results in four patients [in German] Klin Monbl Augenheilkd 217 2000 190 193
17. E. Spoerl, M. Huhle, and T. Seiler Induction of cross-links in corneal tissue Exp Eye Res 66 1998 97 103
18. R.P. Goodrich The use of riboflavin for the inactivation of pathogens in blood products Vox Sang 78 suppl 2000 211 215
19. P.C. Joshi Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical (O2-) mechanisms Toxicol Lett 26 1985 211 217
20. W.T. Speck, C.C. Chen, and H.S. Rosenkranz In vitro studies of effects of light and riboflavin on DNA and HeLa cells Pediatr Res 9 1975 150 153
21. P.H. Ruane, R. Edrich, and D. Gampp Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light Transfusion 44 2004 877 885
22. L.J. Cardo, J. Salata, and J. Mendez Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light Transfus Apher Sci 37 2007 131 137
23. S.A. Martins, J.C. Combs, and G. Noguera Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis Invest Ophthalmol Vis Sci 49 2008 3402 3408
24. M. Kohlhaas, E. Spoerl, and T. Schilde Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light J Cataract Refract Surg 32 2006 279 283
25. N. Lim, D. Goh, and C. Bunce Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis Am J Ophthalmol 145 2008 130 135
26. D.F. Larkin, S. Kilvington, and J.K. Dart Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide Ophthalmology 99 1992 185 191
27. M.S. Osato, N.M. Robinson, K.R. Wilhelmus, and D.B. Jones In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba Rev Infect Dis 13 suppl 1991 S431 S435
28. J. Hay, C.M. Kirkness, D.V. Seal, and P. Wright Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy Eye (Lond) 8 1994 555 563
29. D.W. Clarke, and J.Y. Niederkorn The pathophysiology of Acanthamoeba keratitis Trends Parasitol 22 2006 175 180
30. N.A. Khan Pathogenesis of Acanthamoeba infections Microb Pathog 34 2003 277 285
31. I. Claerhout, A. Goegebuer, C. Van Den Broecke, and P. Kestelyn Delay in diagnosis and outcome of Acanthamoeba keratitis Graefes Arch Clin Exp Ophthalmol 242 2004 648 653
32. H.D. Cavanagh Acanthamoeba keratitis: 2007: a train wreck in slow motion Eye Contact Lens 33 2007 209
33. K.J. Johns, W.S. Head, and D.M. ODay Corneal toxicity of propamidine Arch Ophthalmol 106 1988 68 69
34. S. Murthy, N.R. Hawksworth, and I. Cree Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate (0.02%) Cornea 21 2002 237 239
35. N. Ehlers, and J. Hjortdal Are cataract and iris atrophy toxic complications of medical treatment of Acanthamoeba keratitis? Acta Ophthalmol Scand 82 2004 228 231
36. P.S. Jackett, V.R. Aber, and D.B. Lowrie Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis J Gen Microbiol 104 1978 37 45
37. S. Kilvington, and D.G. White Acanthamoeba: biology, ecology and human disease Rev Med Microbiol 5 1994 12 20
38. B.J. Tripathi, and R.C. Tripathi Hydrogen peroxide damage to human corneal epithelial cells in vitro: implications for contact lens disinfection systems Arch Ophthalmol 107 1989 1516 1519
39. M.V. Riley, and F.J. Giblin Toxic effects of hydrogen peroxide on corneal endothelium Curr Eye Res 2 19821983 451 458
40. C. Mazzotta, A. Balestrazzi, and C. Traversi Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans Cornea 26 2007 390 397
41. G. Wollensak, E. Spoerl, M. Wilsch, and T. Seiler Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment Cornea 23 2004 43 49
42. G. Wollensak, E. Spoerl, M. Wilsch, and T. Seiler Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit J Cataract Refract Surg 29 2003 1786 1790
43. Y.G. He, J.Y. Niederkorn, and J.P. McCulley In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii Invest Ophthalmol Vis Sci 31 1990 2235 2240
44. Y. Goldich, A.L. Marcovich, and Y. Barkana Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus Cornea 29 2010 409 411